Metabolic Disorders
From Proteopedia
(Difference between revisions)
| Line 10: | Line 10: | ||
*[[Molecular_Playground/Human_Protective_Protein_Cathepsin_A|Protective Protein/Cathepsin A (PPCA) 2]] | *[[Molecular_Playground/Human_Protective_Protein_Cathepsin_A|Protective Protein/Cathepsin A (PPCA) 2]] | ||
*[[Bacterial thiolase|Thiolase]] | *[[Bacterial thiolase|Thiolase]] | ||
| - | *[[Treatment_of_Gaucher_disease]] | + | *[[Treatment_of_Gaucher_disease|Treatment of Gaucher Disease]] |
*[[Molecular_Playground/Velaglucerase|Velaglucerase]] | *[[Molecular_Playground/Velaglucerase|Velaglucerase]] | ||
| + | *[[Disulfide Connectivity of Velaglucerase|Velaglucerase Disulfide Connectivity]] | ||
<br /> | <br /> | ||
Revision as of 15:04, 30 September 2010
Metabolic Disorders broadly covers illnesses related to faulty carbohydrate metabolism, amino acid metabolism, organic acid metabolism, or lysosomal storage.
Articles in Proteopedia concerning metabolic disorders include:
- Acid-beta-glucosidase
- ß-2 Microglobulin
- Protective Protein/Cathepsin A (PPCA)
- Protective Protein/Cathepsin A (PPCA) 2
- Thiolase
- Treatment of Gaucher Disease
- Velaglucerase
- Velaglucerase Disulfide Connectivity
To view automatically seeded indices concerning Metabolic Disorderes See:
To view other Proteopedia pages about diseases & drug targets, See: Pharmaceutical Drug Targets
